Thiogenesis to Present at 2026 Bloom Burton Healthcare Investor Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy TTI?
Source: Yahoo Finance
- Investor Conference Presentation: Thiogenesis Therapeutics will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 22, 2026, from 1:30 to 2:00 PM, aiming to showcase its clinical-stage development programs, particularly its late-stage lead program for nephropathic cystinosis.
- Leadership Team Introduction: The presentation will be led by CFO Brook Riggins and CEO and Co-Founder Patrice Rioux, emphasizing the company's focus on serious pediatric diseases with significant unmet medical needs, thereby highlighting its strategic positioning in the biopharmaceutical industry.
- Clinical Development Progress: Thiogenesis is advancing its lead product candidate TTI-0102 toward a Phase 3 clinical trial for nephropathic cystinosis while exploring the expansion of its platform into mitochondrial diseases, including Leigh syndrome, indicating the company's potential in emerging medical fields.
- Industry Context: Bloom Burton & Co. is a leading investment bank focused on the healthcare sector, and its annual investor conference provides a platform for public and private healthcare companies to engage with institutional investors about clinical progress and investment opportunities, further enhancing Thiogenesis's industry visibility.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TTI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TTI
Wall Street analysts forecast TTI stock price to rise
4 Analyst Rating
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 8.520
Low
10.00
Averages
11.50
High
13.00
Current: 8.520
Low
10.00
Averages
11.50
High
13.00
About TTI
TETRA Technologies, Inc. is an energy services and solutions company focused on developing environmentally conscious services and solutions. Its portfolio consists of energy services, industrial chemicals, and lithium ventures. The Company’s segments include Completion Fluids & Products Division and Water & Flowback Services Division. The Completion Fluids & Products Division manufactures and markets clear brine fluids (CBFs), additives, and associated products and services to the oil and gas industry for use in well drilling, completion, and workover operations in the United States and in certain countries in Latin America, Europe, Asia, the Middle East, and Africa. The Water & Flowback Services Division provides a variety of water management services that support hydraulic fracturing in unconventional well completions for domestic onshore oil and gas operators. These services include fresh and produced water analysis, treatment, and recycling, blending and distribution, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Investor Conference Presentation: Thiogenesis Therapeutics will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 22, 2026, from 1:30 to 2:00 PM, aiming to showcase its clinical-stage development programs, particularly its late-stage lead program for nephropathic cystinosis.
- Leadership Team Introduction: The presentation will be led by CFO Brook Riggins and CEO and Co-Founder Patrice Rioux, emphasizing the company's focus on serious pediatric diseases with significant unmet medical needs, thereby highlighting its strategic positioning in the biopharmaceutical industry.
- Clinical Development Progress: Thiogenesis is advancing its lead product candidate TTI-0102 toward a Phase 3 clinical trial for nephropathic cystinosis while exploring the expansion of its platform into mitochondrial diseases, including Leigh syndrome, indicating the company's potential in emerging medical fields.
- Industry Context: Bloom Burton & Co. is a leading investment bank focused on the healthcare sector, and its annual investor conference provides a platform for public and private healthcare companies to engage with institutional investors about clinical progress and investment opportunities, further enhancing Thiogenesis's industry visibility.
See More
- Earnings Release Schedule: TETRA Technologies will release its Q1 2026 results after market close on April 29, 2026, which is expected to provide critical financial data and business performance insights, aiding investors in assessing the company's current market position and future growth potential.
- Executive Conference Call: CEO Brady Murphy and CFO Matt Sanderson will host a conference call on April 30, 2026, at 10:30 AM ET to discuss the earnings results and outlook, enhancing transparency and engaging with investors directly.
- Company Overview: TETRA Technologies is an energy services company focused on environmentally conscious solutions, operating across six continents with a portfolio that includes Energy Services, Industrial Chemicals, and Critical Minerals, aimed at improving quality of life.
- Expansion into Low-Carbon Energy: The company is expanding into the low-carbon energy market, leveraging its chemistry expertise and global infrastructure to meet the growing demand for sustainable energy in the 21st century, highlighting its strategic significance in the energy transition.
See More
- Earnings Release Schedule: TETRA Technologies will release its Q1 2026 results after market close on April 29, 2026, expected to provide key financial data and future outlook, aiding investors in assessing company performance.
- Executive Conference Call: CEO Brady Murphy and CFO Matt Sanderson will host a conference call on April 30, 2026, at 10:30 AM ET to discuss the earnings report and market outlook, enhancing transparency and investor confidence.
- Company Overview: TETRA Technologies is an energy services company focused on environmentally conscious services and solutions, operating across six continents, with a portfolio that includes Energy Services, Industrial Chemicals, and Critical Minerals, aimed at meeting 21st-century sustainable energy demands.
- Market Expansion Strategy: The company not only provides products and services to the oil and gas industry but is also expanding into the low-carbon energy market, leveraging chemistry expertise and global infrastructure to drive sustainable energy development.
See More

- Investor Meeting Schedule: TETRA Technologies' CEO Brady Murphy and executive team will host one-on-one meetings with institutional investors on March 17, 2026, at the Piper Sandler 26th Annual Energy Conference in Las Vegas, aiming to enhance communication and relationships with investors.
- Company Overview: TETRA Technologies is an energy services company focused on developing environmentally conscious services and solutions, operating across six continents, and encompassing Energy Services, Industrial Chemicals, and Critical Minerals to improve people's quality of life.
- Expansion into Low-Carbon Energy: The company is not only providing products and services to the oil and gas industry but is also expanding into the low-carbon energy market, leveraging its chemistry expertise and global infrastructure to meet the growing demand for sustainable energy in the 21st century.
- Diverse Product Portfolio: TETRA's product offerings include calcium chloride for various applications, showcasing its diversity and adaptability in the industrial chemicals sector, further solidifying its position in the energy services industry.
See More
- Investor Meeting Schedule: TETRA Technologies will host one-on-one meetings with institutional investors on March 17, 2026, at the Piper Sandler 26th Annual Energy Conference in Las Vegas, aiming to strengthen investor relations and showcase the company's growth potential.
- Executive Participation: CEO Brady Murphy, CFO Elijio Serrano, and VP of Investor Relations Kurt Hallead will personally lead the meetings, indicating the company's commitment to investor communication and transparency.
- Company Overview: TETRA is an energy services company focused on developing environmentally conscious services and solutions, with operations across six continents, encompassing energy services, industrial chemicals, and critical minerals, dedicated to meeting the demand for sustainable energy in the 21st century.
- Market Expansion Strategy: The company is expanding into the low-carbon energy market, leveraging its chemistry expertise and global infrastructure to drive sustainable energy development, highlighting its strategic significance in the energy transition.
See More
- Significant Revenue Growth: In 2025, TETRA's revenue from the Gulf of America increased by over 50% compared to 2024, primarily driven by participation in deepwater projects, including the completion of three CS Neptune wells, showcasing the company's strong performance in a high-demand market.
- EBITDA Margin Improvement: The Completion Fluids & Products segment saw EBITDA margins rise from 28.9% in 2024 to 33% in 2025, attributed to innovation and vertical integration, indicating the company's ongoing improvements in cost control and product quality.
- Robust Cash Flow: In Q4 2025, cash flow from the base business reached $21.8 million, with total free cash flow for the year at $83 million, reflecting the company's financial health, while year-end cash reserves doubled to $73 million, and net debt decreased to $109 million.
- Optimistic Future Outlook: Revenue from Argentina is expected to double in 2026, driven by new contracts and SandStorm technology, while adjusted EBITDA margins for Completion Fluids & Products are projected between 25% and 30%, despite rising costs from third-party bromine supplies.
See More









